These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

929 related articles for article (PubMed ID: 12216096)

  • 41. [A randomized comparative trial of three combined regimens containing cisplatin for treatment of advanced non-small cell lung cancer].
    Liu L; Wang XW; Li L; Zhang X; Zhang WD; Yu XJ
    Ai Zheng; 2006 Aug; 25(8):990-4. PubMed ID: 16965680
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG).
    Kosmidis PA; Fountzilas G; Eleftheraki AG; Kalofonos HP; Pentheroudakis G; Skarlos D; Dimopoulos MA; Bafaloukos D; Pectasides D; Samantas E; Boukovinas J; Lambaki S; Katirtzoglou N; Bakogiannis C; Syrigos KN
    Ann Oncol; 2011 Apr; 22(4):827-834. PubMed ID: 20880999
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer.
    Mazzanti P; Massacesi C; Rocchi MB; Mattioli R; Lippe P; Trivisonne R; Buzzi F; De Signoribus G; Tuveri G; Rossi G; Di Lullo L; Sturba F; Morale D; Catanzani S; Pilone A; Bonsignori M; Battelli T
    Lung Cancer; 2003 Jul; 41(1):81-9. PubMed ID: 12826316
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431.
    Vokes EE; Herndon JE; Crawford J; Leopold KA; Perry MC; Miller AA; Green MR
    J Clin Oncol; 2002 Oct; 20(20):4191-8. PubMed ID: 12377962
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial.
    Gridelli C; Cigolari S; Gallo C; Manzione L; Ianniello GP; Frontini L; Ferraù F; Robbiati SF; Adamo V; Gasparini G; Novello S; Perrone F;
    Lung Cancer; 2001; 31(2-3):277-84. PubMed ID: 11165408
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interim analysis of a phase III trial. Triple- vs double-agent chemotherapy for advanced non-small-cell lung cancer. Southern Italy Cooperative Oncology Group.
    Comella P
    Oncology (Williston Park); 2000 Jul; 14(7 Suppl 4):35-40. PubMed ID: 10960944
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomized study of vinorelbine--gemcitabine versus vinorelbine--carboplatin in patients with advanced non-small cell lung cancer.
    Tan EH; Szczesna A; Krzakowski M; Macha HN; Gatzemeier U; Mattson K; Wernli M; Reiterer P; Hui R; Pawel JV; Bertetto O; Pouget JC; Burillon JP; Parlier Y; Abratt R;
    Lung Cancer; 2005 Aug; 49(2):233-40. PubMed ID: 16022917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance.
    Prescrire Int; 2005 Feb; 14(75):16-8. PubMed ID: 15751170
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Phase III clinical trials concerning non-small-cell lung carcinoma (NSCLC) presented at the ASCO 2001].
    Morere JF
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S37-41. PubMed ID: 11924242
    [No Abstract]   [Full Text] [Related]  

  • 50. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
    Hainsworth JD; Burris HA; Morrissey LH; Thomas M; Erland JB; Butts JA; Joseph G; Kalman L; Greco FA
    Cancer J; 2000; 6(3):151-6. PubMed ID: 10882330
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemotherapy for non-small cell lung cancer: have we reached a new plateau?
    Shepherd FA
    Semin Oncol; 1999 Feb; 26(1 Suppl 4):3-11. PubMed ID: 10201515
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gemcitabine and vinorelbine as second-line therapy for non-small cell lung cancer after treatment with paclitaxel plus platinum.
    Park YH; Lee JC; Kim CH; Ryoo BY; Kim HT
    Jpn J Clin Oncol; 2004 May; 34(5):245-9. PubMed ID: 15231858
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gemcitabine-docetaxel versus cisplatin-vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin.
    Pujol JL; Breton JL; Gervais R; Rebattu P; Depierre A; Morère JF; Milleron B; Debieuvre D; Castéra D; Souquet PJ; Moro-Sibilot D; Lemarié E; Kessler R; Janicot H; Braun D; Spaeth D; Quantin X; Clary C
    Ann Oncol; 2005 Apr; 16(4):602-10. PubMed ID: 15741225
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase II study of alternating chemotherapy regimens for advanced non-small cell lung cancer.
    Stewart DJ; Tomiak E; Shamji FM; Maziak DE; MacLeod P
    Lung Cancer; 2004 May; 44(2):241-9. PubMed ID: 15084389
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Metastatic non-small cell lung cancer: Systemic treatment of patients aged 70 and over].
    Quoix E; Ducoloné A; Mennecier B; Fraisse P
    Presse Med; 2011 Apr; 40(4 Pt 1):420-6. PubMed ID: 21388776
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trials.
    Pujol JL; Barlesi F; Daurès JP
    Lung Cancer; 2006 Mar; 51(3):335-45. PubMed ID: 16478643
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Randomized trial comparing cisplatin, gemcitabine, and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer: interim analysis of a phase III trial of the Southern Italy Cooperative Oncology Group.
    Comella P; Frasci G; Panza N; Manzione L; De Cataldis G; Cioffi R; Maiorino L; Micillo E; Lorusso V; Di Rienzo G; Filippelli G; Lamberti A; Natale M; Bilancia D; Nicolella G; Di Nota A; Comella G
    J Clin Oncol; 2000 Apr; 18(7):1451-7. PubMed ID: 10735892
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology Group.
    Comella P; Frasci G; Panza N; Manzione L; Lorusso V; Di Rienzo G; Cioffi R; De Cataldis G; Maiorino L; Bilancia D; Nicolella G; Natale M; Carpagnano F; Pacilio C; De Lena M; Bianco A; Comella G
    J Clin Oncol; 1999 May; 17(5):1526-34. PubMed ID: 10334540
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of histology with common first-line regimens for advanced non-small cell lung cancer: a brief report of the retrospective analysis of a three-arm randomized trial.
    Scagliotti GV; De Marinis F; Rinaldi M; Crinò L; Gridelli C; Ricci S; Zhao YD; Liepa AM; Peterson P; Tonato M
    J Thorac Oncol; 2009 Dec; 4(12):1568-71. PubMed ID: 20009911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Second-Line docetaxel and gemcitabine combination chemotherapy in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: a phase II trial.
    Tas F; Demir C; Camlica H; Ustuner Z; Topuz E
    Med Oncol; 2004; 21(3):233-40. PubMed ID: 15456950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.